ストックスクリーナーアプリを入手
8.046
5.26%
-0.434
前日終値:
$8.48
開ける：
$8.4
24時間の取引高:
2.03M
Relative Volume:
1.01
時価総額：
$1.40B
収益：
$25.55M
当期純損益:
$-341.97M
株価収益率:
-2.8736
EPS:
-2.8
ネットキャッシュフロー:
$-304.44M
1週間 パフォーマンス:
+5.85%
1か月 パフォーマンス:
+21.36%
6か月 パフォーマンス:
+162.56%
1年 パフォーマンス:
+78.54%
1日の値動き範囲:
$7.95
$8.50
1週間の範囲:
$7.55
$9.04
52週間の値動き範囲:
$1.775
$9.04
Relay Therapeutics Inc Stock (RLAY) Company Profile
RLAY を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
RLAY
Relay Therapeutics Inc
|
8.055 | 1.47B | 25.55M | -341.97M | -304.44M | -2.80 |
|
VRTX
Vertex Pharmaceuticals Inc
|
448.48 | 115.43B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
749.84 | 78.44B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
861.11 | 52.42B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
391.86 | 51.68B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
199.46 | 42.80B | 447.02M | -1.18B | -906.14M | -6.1812 |
Relay Therapeutics Inc Stock (RLAY) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-12-12 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2025-09-04 | 再開されました | Guggenheim | Buy |
| 2025-04-17 | 開始されました | Wells Fargo | Equal Weight |
| 2024-09-10 | 再開されました | Goldman | Buy |
| 2024-09-10 | アップグレード | Jefferies | Hold → Buy |
| 2024-09-10 | ダウングレード | Oppenheimer | Outperform → Perform |
| 2024-05-10 | アップグレード | Barclays | Equal Weight → Overweight |
| 2023-04-20 | アップグレード | Jefferies | Underperform → Hold |
| 2023-04-19 | アップグレード | Raymond James | Outperform → Strong Buy |
| 2023-04-13 | 開始されました | Raymond James | Outperform |
| 2023-02-03 | 開始されました | Oppenheimer | Outperform |
| 2022-09-30 | 開始されました | Barclays | Equal Weight |
| 2022-09-02 | 開始されました | Stifel | Buy |
| 2022-06-06 | 開始されました | Jefferies | Underperform |
| 2022-02-01 | 開始されました | Berenberg | Buy |
| 2021-07-21 | 開始されました | BofA Securities | Buy |
| 2020-12-15 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-12-08 | 開始されました | JMP Securities | Mkt Outperform |
| 2020-11-05 | 開始されました | H.C. Wainwright | Buy |
| 2020-08-10 | 開始されました | Cowen | Outperform |
| 2020-08-10 | 開始されました | Goldman | Buy |
| 2020-08-10 | 開始されました | Guggenheim | Buy |
| 2020-08-10 | 開始されました | JP Morgan | Neutral |
すべてを表示
Relay Therapeutics Inc (RLAY) 最新ニュース
Relay Therapeutics Stock Has Jumped 60% in a Year — And One Investor Just Bought Nearly 4 Million More Shares - AOL.com
Alert from Equity-Insider.com was published in error and has been withdrawn - marketscreener.com
Relay Therapeutics (NASDAQ:RLAY) Trading Up 4.7%Here's What Happened - MarketBeat
Relay Therapeutics (RLAY): Revisiting Valuation After a Sharp Rebound in 2024 - Yahoo Finance
Will Broad Zovegalisib Breast Cancer Data Reshape Relay Therapeutics' (RLAY) Targeted Oncology Narrative? - Yahoo Finance
Relay Therapeutics (NASDAQ:RLAY) Sets New 1-Year HighStill a Buy? - MarketBeat
Bellevue Group AG Boosts Stake in Relay Therapeutics, Inc. $RLAY - MarketBeat
Wells Fargo Upgrades Relay Therapeutics (RLAY) - Nasdaq
Why Is Relay Therapeutics Stock Gaining Friday?Relay Therapeutics (NASDAQ:RLAY) - Benzinga
RLAY Stock Receives Analyst Upgrade and Price Target Boost | RLA - GuruFocus
Relay Therapeutics stock hits 52-week high at 8.62 USD By Investing.com - Investing.com Nigeria
Relay Therapeutics stock hits 52-week high at 8.62 USD - Investing.com
Relay Therapeutics Reports 'Robust Activity' in Study of Zovegalisib to Treat Breast Cancer - marketscreener.com
Relay Therapeutics (RLAY) Shares New Data from Zovegalisib Study - GuruFocus
Relay Therapeutics unveils efficacy subset analysis for zovegalisib at SABCS25 - Traders Union
Relay Therapeutics Reports Positive Efficacy Data for Zovegalisib in Metastatic Breast Cancer at SABCS 2025 - Quiver Quantitative
Relay Therapeutics Announces Efficacy Subset Analysis of - GlobeNewswire
OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC Cuts Stock Holdings in Relay Therapeutics, Inc. $RLAY - MarketBeat
149,701 Shares in Relay Therapeutics, Inc. $RLAY Acquired by HighVista Strategies LLC - MarketBeat
Here's Why Relay Therapeutics, Inc. (RLAY) is a Great Momentum Stock to Buy - MSN
Norges Bank Buys Shares of 835,874 Relay Therapeutics, Inc. $RLAY - MarketBeat
Diadema Partners LP Has $151,000 Stake in Relay Therapeutics, Inc. $RLAY - MarketBeat
Mixed Investor Sentiment Surrounds Relay Therapeutics Stock - AD HOC NEWS
Growth Value: Why Relay Therapeutics Inc stock could outperform in 20252025 Market Trends & Technical Pattern Recognition Alerts - moha.gov.vn
JPMorgan Chase & Co. Reduces Stock Holdings in Relay Therapeutics, Inc. $RLAY - MarketBeat
Relay Therapeutics (NASDAQ:RLAY) Shares Down 5%What's Next? - MarketBeat
Relay Therapeutics, Inc. $RLAY Position Lifted by Franklin Resources Inc. - MarketBeat
Is Relay Therapeutics Inc. stock gaining market shareJuly 2025 Rallies & Low Drawdown Investment Strategies - Newser
Relay Therapeutics, Inc. $RLAY Shares Bought by Geode Capital Management LLC - MarketBeat
XTX Topco Ltd Raises Stake in Relay Therapeutics, Inc. $RLAY - MarketBeat
Is Relay Therapeutics Inc. stock a buy on dipsWeekly Trade Analysis & Fast Moving Stock Trade Plans - Newser
Relay Therapeutics, Inc. (NASDAQ:RLAY) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
What makes Relay Therapeutics Inc. stock attractive to growth fundsMarket Performance Recap & Expert Curated Trade Ideas - moha.gov.vn
RLAY Stock Price and Chart — NASDAQ:RLAY - TradingView
Barclays Sticks to Its Buy Rating for Relay Therapeutics (RLAY) - The Globe and Mail
Relay Therapeutics stock hits 52-week high at $7.65 By Investing.com - Investing.com Nigeria
Relay Therapeutics stock hits 52-week high at $7.65 - Investing.com
Should I hold or sell Relay Therapeutics Inc. stock in 2025CEO Change & AI Based Buy and Sell Signals - newser.com
Key metrics from Relay Therapeutics Inc.’s quarterly data2025 Dividend Review & Technical Entry and Exit Alerts - newser.com
Is Relay Therapeutics Inc. stock a top momentum playJuly 2025 Drop Watch & Daily Market Momentum Tracking - newser.com
Relay Therapeutics Inc.’s volatility index tracking explainedJuly 2025 Price Swings & Capital Protection Trading Alerts - newser.com
Relay Therapeutics Inc. (RLAY) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Top 3 Biotech Stocks Capitalizing on the AI Revolution - Investing.com
Top 3 Biotech Stocks Capitalizing on the AI Revolution - Investing.com
Commit To Buy Relay Therapeutics At $5, Earn 22.4% Annualized Using Options - Nasdaq
Citizens reiterates Market Outperform rating on Relay Therapeutics stock By Investing.com - Investing.com Canada
Persistent Asset Partners Ltd Decreases Stock Position in Relay Therapeutics, Inc. $RLAY - MarketBeat
What analysts say about Relay Therapeutics Inc stockChart Pattern Recognition & Outstanding Growth Strategies - earlytimes.in
How Relay Therapeutics Inc. stock compares to growth peersTrade Performance Summary & AI Optimized Trade Strategies - newser.com
Relay Therapeutics Inc (RLAY) 財務データ
収益
当期純利益
現金流量
EPS
Relay Therapeutics Inc (RLAY) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Rahmer Peter | See remarks |
Oct 29 '25 |
Sale |
7.50 |
21,394 |
160,455 |
337,469 |
| Rahmer Peter | See remarks |
Oct 28 '25 |
Sale |
7.29 |
19,135 |
139,494 |
358,863 |
| Catinazzo Thomas | Chief Financial Officer |
Oct 28 '25 |
Sale |
7.29 |
21,664 |
157,931 |
313,631 |
| Bergstrom Donald A | President, R&D |
Oct 28 '25 |
Sale |
7.29 |
30,897 |
225,239 |
521,823 |
0.39%
0.31%
大文字化:
|
ボリューム (24 時間):